Cross-Functional Program Leadership • Data Governance • Process Excellence • Pharma & Cell Therapy Expertise

Date of management change: September 08, 2025 

What Happened?

 

About the Company

Autolus is a clinical-stage biopharmaceutical company developing next-generation, programmed T cell therapies for the treatment of cancer. Using a broad suite of proprietary and modular T cell programming technologies, the Company is engineering precisely targeted, controlled and highly active T cell therapies that are designed to better recognize cancer cells, break down their defense mechanisms and eliminate these cells. Autolus has a pipeline of product candidates in development for the treatment of hematological malignancies and solid tumors.

 

About the Person

 

Info Source

News

 
 

Other IT executives who recently changed jobs as well: Egan Christopher, Papahronis Tom, Fetcho Nicholas, Peck John, Lindley John, O'Shaughnessy Bryan, Stone Laurette, Carr Cynthia, Mill James, Norris Rob, Franks Justin

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.